Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP491828.RA4IR91BE1UHeXvL7jkENxBSNOkcVBUpt--O8gs2lEoxo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP491828.RA4IR91BE1UHeXvL7jkENxBSNOkcVBUpt--O8gs2lEoxo130_assertion type Assertion NP491828.RA4IR91BE1UHeXvL7jkENxBSNOkcVBUpt--O8gs2lEoxo130_head.
- NP491828.RA4IR91BE1UHeXvL7jkENxBSNOkcVBUpt--O8gs2lEoxo130_assertion description "[We studied the responses of bcl-2 and bcl-X(L) genes in pharmacologic (acute incubation with methylpyridinium (MPP+)) and mitochondrial transgenic (`cybrid`) models of Parkinson disease C-I defects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP491828.RA4IR91BE1UHeXvL7jkENxBSNOkcVBUpt--O8gs2lEoxo130_provenance.
- NP491828.RA4IR91BE1UHeXvL7jkENxBSNOkcVBUpt--O8gs2lEoxo130_assertion evidence source_evidence_literature NP491828.RA4IR91BE1UHeXvL7jkENxBSNOkcVBUpt--O8gs2lEoxo130_provenance.
- NP491828.RA4IR91BE1UHeXvL7jkENxBSNOkcVBUpt--O8gs2lEoxo130_assertion SIO_000772 10972966 NP491828.RA4IR91BE1UHeXvL7jkENxBSNOkcVBUpt--O8gs2lEoxo130_provenance.
- NP491828.RA4IR91BE1UHeXvL7jkENxBSNOkcVBUpt--O8gs2lEoxo130_assertion wasDerivedFrom befree-20140225 NP491828.RA4IR91BE1UHeXvL7jkENxBSNOkcVBUpt--O8gs2lEoxo130_provenance.
- NP491828.RA4IR91BE1UHeXvL7jkENxBSNOkcVBUpt--O8gs2lEoxo130_assertion wasGeneratedBy ECO_0000203 NP491828.RA4IR91BE1UHeXvL7jkENxBSNOkcVBUpt--O8gs2lEoxo130_provenance.